| Solubility and solution stability studies of different amino acid prodrugs of bromhexine. | |
| | |
MedLine Citation:
|
PMID: 22283553 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Objective: The aim of the present study was to prepare the amino acid prodrugs of bromhexine hydrochloride to improve its solubility. Methods: All the prodrugs were synthesized by first reacting bromhexine with tert-butoxycarbonyl (Boc) protected amino acid and then deprotection was carried out by using trifluoroacetic acid. These prodrugs were characterized by their melting points, NMR, mass and FTIR spectroscopy. Solubility and partition coefficient of bromhexine and various prodrugs were determined. The solution stability of various prodrugs was also determined in various buffers of pH ranging from 2 to 10. Degradation rate constants and half-life were also determined at various pH. Results and discussion: The structures of all the synthesized prodrugs were confirmed by NMR, mass and FTIR spectra. The prodrug 2-N-l-alanyl-bromhexine hydrochloride showed maximum solubility and minimum partition coefficient value. These prodrugs may hydrolyze by one or more mechanisms. The order of decreasing rates of hydrolysis was 2-N-l-prolyl-bromhexine hydrochloride > 2-N-glycyl-bromhexine hydrochloride > 2-N-l-alanyl-bromhexine hydrochloride. All the prodrugs exhibited maximum stability in the acidic pH range and undergo base catalyzed hydrolysis. Conclusion: Solubility studies and partition coefficient values indicated that the synthesized prodrug, 2-N-l-alanyl-bromhexine hydrochloride, was least lipophilic as compared to other synthesized prodrugs. Solution stability studies showed that this prodrug undergo minimum hydrolysis at 37°C. So, it is concluded that 2-N-l-alanyl-bromhexine hydrochloride exhibits better solubility and stability as compared to other synthesized prodrugs. |
| | |
Authors:
|
Amit Kumar Aggarwal; Mukta Gupta |
Related Documents
:
|
6145553 - Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from lab... 10963063 - Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monk... 8257103 - The surface trans-sialidase family of trypanosoma cruzi. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-28 |
Journal Detail:
|
Title: Drug development and industrial pharmacy Volume: - ISSN: 1520-5762 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7802620 Medline TA: Drug Dev Ind Pharm Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pharmaceutical Chemistry, Rayat Institute of Pharmacy , Punjab , India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Amiodarone ( Nexterone ) injection for the treatment and prophylaxis of frequently recurring ventric...
Next Document: Re-electrospraying splash landed proteins and nanoparticles.